BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9184233)

  • 41. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N; DePinho RA
    Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
    Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
    Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequence signatures and the probabilistic identification of proteins in the Myc-Max-Mad network.
    Atchley WR; Fernandes AD
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6401-6. PubMed ID: 15851686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J; Lüscher B
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM; Eisenman RN
    Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A basic helix-loop-helix-leucine zipper transcription complex in yeast functions in a signaling pathway from mitochondria to the nucleus.
    Jia Y; Rothermel B; Thornton J; Butow RA
    Mol Cell Biol; 1997 Mar; 17(3):1110-7. PubMed ID: 9032238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25.
    Shapiro DN; Valentine V; Eagle L; Yin X; Morris SW; Prochownik EV
    Genomics; 1994 Sep; 23(1):282-5. PubMed ID: 7829091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Rao G; Guida P; Skoultchi AI; DePinho RA
    Cell; 1995 Mar; 80(5):777-86. PubMed ID: 7889571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
    Muhle-Goll C; Nilges M; Pastore A
    Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.
    Walhout AJ; Gubbels JM; Bernards R; van der Vliet PC; Timmers HT
    Nucleic Acids Res; 1997 Apr; 25(8):1493-501. PubMed ID: 9162900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
    Popov N; Wahlström T; Hurlin PJ; Henriksson M
    Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assembly of b/HLH/z proteins c-Myc, Max, and Mad1 with cognate DNA: importance of protein-protein and protein-DNA interactions.
    Hu J; Banerjee A; Goss DJ
    Biochemistry; 2005 Sep; 44(35):11855-63. PubMed ID: 16128587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of a two-hybrid system to identify mutations in Max that confer increased affinity for Myc.
    Wang H; Van Den Bergh F; Spencer E; Wilcox K; Herman T
    DNA Cell Biol; 1997 Nov; 16(11):1277-88. PubMed ID: 9407000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WBSCR14, a gene mapping to the Williams--Beuren syndrome deleted region, is a new member of the Mlx transcription factor network.
    Cairo S; Merla G; Urbinati F; Ballabio A; Reymond A
    Hum Mol Genet; 2001 Mar; 10(6):617-27. PubMed ID: 11230181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
    J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG; Bahram F; Burkhardt H; Lüscher B
    Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.
    Xu J; Chen G; De Jong AT; Shahravan SH; Shin JA
    J Am Chem Soc; 2009 Jun; 131(22):7839-48. PubMed ID: 19449889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.